New drug combo for schizophrenia shows promise in small study
NCT ID NCT05169268
First seen May 02, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study looked at whether combining two antipsychotic medications (Abilify Maintena and Rexulti) helps control symptoms of schizophrenia better than one alone. Six adults with schizophrenia or related disorders were followed for 6 months. Researchers measured changes in psychotic, anxiety, and depression symptoms, as well as side effects like muscle stiffness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Queen Mary Hospital
Hong Kong, 000000, Hong Kong
Conditions
Explore the condition pages connected to this study.